Having observed the impact of NEK2i on the ability of CDK4/6i to induce CIN, we asked whether blocking other mitotic kinases may also increase the efficacy of CDK4/6i in vivo, without inducing toxicity. Here, CDK4 is linked to cervical squamous intraepithelial neoplasia.